Therapeuticsmd Share Price (NASDAQ: TXMD)
$1.11
Last updated on
Check the interactive Therapeuticsmd Stock chart to analyse performance
Therapeuticsmd stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$1.10Today's High:$1.11
0.9%
Downside
Day's Volatility :0.9%
Upside
0.0%
- 52 Weeks Low:$0.7052 Weeks High:$2.44
36.94%
Downside
52 Weeks Volatility :71.31%
Upside
54.51%
Therapeuticsmd Stock Returns
Therapeuticsmd, Inc. Key Stats
Check Therapeuticsmd key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Therapeuticsmd Stock including INR - Dollar returns
The Therapeuticsmd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Therapeuticsmd investment value today
Current value as on today
₹67,295
Returns
Returns from Therapeuticsmd Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Therapeuticsmd Stock
Global Institutional Holdings in Therapeuticsmd, Inc.
Name
Holdings %
Rubric Capital Management LP
10.30%
Clearline Capital LP
5.49%
Vanguard Group Inc
3.27%
Tejara Capital Ltd
2.97%
ADAR1 Capital Management LLC
2.33%
Morgan Stanley - Brokerage Accounts
1.13%
Analyst Recommendation on Therapeuticsmd Stock
Sell
0%Buy
50%Hold
50%Sell
Based on 6 Wall street analysts offering stock ratings for Therapeuticsmd(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Therapeuticsmd Share Price Target
What analysts predicted
Upside of 350.45%
Target:
$5.00
Current:
$1.11
Therapeuticsmd share price target is $5.00, a slight Upside of 350.45% compared to current price of $1.11 as per analysts' prediction.
Therapeuticsmd Stock Insights
Price Movement
In the last 3 months, TXMD stock has moved down by -24.7%Increasing Revenue
Revenue is up for the last 2 quarters, 393.0K → 952.0K (in $), with an average increase of 58.7% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -653.0K → 551.0K (in $), with an average increase of 218.5% per quarterTXMD vs NBIX (1 yr)
In the last 1 year, Neurocrine Biosciences Inc. has given 9.9% return, outperforming this stock by 51.5%TXMD vs HLN (3 yr)
In the last 3 years, Haleon Plc Spon Ads has given 33.4% return, outperforming this stock by 122.3%Price to Sales
ForTXMD every $1 of sales, investors are willing to pay $5.0, whereas for Neurocrine Biosciences Inc., the investors are paying $5.6 for every $1 of sales.
Therapeuticsmd Technicals Summary
Sell
Neutral
Buy
Therapeuticsmd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Therapeuticsmd, Inc. Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -0.9% | 27.17% | -38.55% | -88.84% | -98.38% |
 | 1.5% | -7.33% | -3.49% | 69.05% | 32.32% |
 | 3.57% | -1.69% | -13.51% | 34.83% | 71.41% |
 | 6.13% | -8.28% | -14.8% | -1.88% | -3.48% |
 | 8.29% | 21.94% | 11.59% | 32.16% | 20.59% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 0.44 | NA | -0.73 | 0.0 | -0.02 | -0.04 | NA | 2.36 |
| 21.53 | 21.53 | 3.14 | 0.49 | 0.09 | 0.05 | 0.01 | 1.77 |
| 11.9 | 11.9 | 1.43 | 26.59 | 0.19 | 0.13 | NA | 158.65 |
| 26.97 | 26.97 | 2.53 | 6.33 | 0.53 | 0.15 | 0.01 | 11.21 |
| 41.3 | 41.3 | 0.27 | 6.74 | 0.13 | 0.09 | NA | 27.22 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Sell | $13.0M | -98.38% | 0.44 | -17.94% |
| Buy | $43.4B | 32.32% | 21.53 | 13.81% |
| Buy | $13.8B | 71.41% | 11.9 | 40.36% |
| Buy | $69.3B | -3.48% | 26.97 | 27.83% |
| Buy | $13.8B | 20.59% | 41.3 | 13.88% |
About Therapeuticsmd, Inc.
Key Management of Therapeuticsmd, Inc.
Important FAQs about investing in TXMD Stock from India :
What is Therapeuticsmd share price today?
Therapeuticsmd share price today is $1.11 as on at the close of the market. Therapeuticsmd share today touched a day high of $1.11 and a low of $1.10.
What is the 52 week high and 52 week low for Therapeuticsmd share?
Therapeuticsmd share touched a 52 week high of $2.44 and a 52 week low of $0.70. Therapeuticsmd stock price today i.e. is closed at $1.11, lower by 54.51% versus the 52 week high.
How to invest in Therapeuticsmd Stock (TXMD) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Therapeuticsmd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Therapeuticsmd Shares that will get you 1.3514 shares as per Therapeuticsmd share price of $1.11 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Therapeuticsmd Stock (TXMD) from India?
Indian investors can start investing in Therapeuticsmd (TXMD) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Therapeuticsmd stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Therapeuticsmd share’s latest price of $1.11 as on August 30, 2025 at 1:29 am IST, you will get 9.0090 shares of Therapeuticsmd. Learn more about
fractional shares .
What are the returns that Therapeuticsmd has given to Indian investors in the last 5 years?
Therapeuticsmd stock has given -98.38% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Webs Defined Volatility Xle$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%